Blockchain networks face a quiet but serious problem that grows over time. As transactions pile up, nodes must store more ...

For many students, mathematics feels less like a subject and more like a verdict, you’re either “good at it” or you’re not. There’s no escape from maths in school, and for some, every class brings a ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. In October 2024, news broke that Facebook parent company Meta had cracked an "impossible" problem ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

In October 2024 Luke Durant, an independent researcher in San Jose, Calif., announced that he had discovered the largest known prime number—so enormous it would take years to write out in full. One ...

Journal Editorial Report: The week's best and worst from Kim Strassel, Jason Riley and Dan Henninger. Remember when the University of California kicked off a trend by eliminating the SAT test as an ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...